Name: UK Life Sciences Winter Forecast
Start: 2023-12-07T14:00:00+00:00
End: 2023-12-07T18:30:00+00:00

Headline Presenting Partner

DTRE is an award-winning, independent commercial property adviser specialising in industrials, logistics, office and life sciences. Wrapping over three decades of blue-chip experience into a more focused, differentiated, data-driven platform, DTRE delivers specialised investment, development and leasing advice to clients throughout the UK and Europe from our offices in London, Manchester and Cambridge.

With more than 60 years of combined life sciences expertise, and first-hand client-side experience, DTRE has a unique and comprehensive understanding of the life-science sector. The business provides clients with unparalleled insights and analysis for informed decision-making, delivering individually tailored solutions to investors, developers and occupiers alike.

DTRE is Planet Mark certified and the winner of the UK Broker, European Real Estate Brand Award. For more information, please visit www.dtre.com.

SOLD OUT

Demand is skyrocketing for all things Life Sciences. UK Life Sciences Winter Forecast is officially sold out. But, don't worry, we have some good news for you...

Secure your ticket at the lowest price available to The UK Life Sciences Real Estate Annual Conference on 6 March!

View the lineup and register today:

The UK Life Sciences Real Estate Annual Conference

2024 UK Life Sciences Event

Looking for more on this topic? Check out our 2024 event here: https://www.bisnow.com/events/london/life-sciences/life-sciences-and-innovation-real-estate-annual-conference-8474

Event Host

Canary Wharf Group & Kadans Science Partner

About Canary Wharf Group:

Canary Wharf Group (CWG) is the developer of the largest urban regeneration project in Europe and integrates sustainability at its core. CWG develops, manages and currently owns interests in approximately 9 million square feet of mixed-use space and over 1,100 Build to Rent apartments. CWG purchases 100% electricity from renewable sources since 2012 and zero waste to landfill from managed areas since 2009 and has a partnership with the Eden Project to create a space which works for nature as well as people.

CWG has created a 24/7 city where people can live, work and thrive on the Canary Wharf estate and enjoy all the benefits: great transport links, access to green spaces and waterside living; and a wide range of amenities including an award-winning arts and events programme. Canary Wharf’s retail offering comprises over 300 shops, including grocery stores, pharmacies, health clubs, bars and restaurants, all within 15 minutes’ walk.

The Company’s current £1.3bn construction activity is composed of 500,000 square feet of commercial properties and over 1,600 new homes for sale and rent.

About Kadans Science Partner:

Kadans Science Partner is the European leader investing in the development of ecosystems and real estate with a dedicated focus on the knowledge intensive sector. Kadans has invested across various specific areas, like agri-tech in Wageningen, life sciences in Leiden, and cell & gene therapy in Stevenage, UK. Kadans provides its tenants with an array of additional services tailored to their specific needs. In December 2020, Kadans was acquired by AXA IM Alts, which, as a long- term capital partner, has allowed us to significantly accelerate our growth.

Kadans is currently present on 26 campuses, in 7 countries, where it operates over 7 million sq ft of space for over 400 tenants, including start-ups, scale-ups, corporates, government bodies and educational institutes. Kadans has a solid view of the developments our tenants and partners are currently working on and which parties in our network could benefit from connecting.

Speakers and Panels

Life Science Platform Investment Insights: Strategies, Risks, And Returns

Explore What Makes A Life Science Platform Attractive To An Investor In The Current Market

Richard Archer

Managing Director, Canary Wharf Group

Robert Holl

Principal, Wellcome Trust

Roshni Prasad

Senior Investment Manager, Department for Business and Trade

Moderator

Chris Cartwright

Partner, Addleshaw Goddard

Smart Sites: Examine The Key Costs & Considerations In Construction And Development

Learn How To Select The Best Site Through Appropriate Due Diligence And Navigate Issues Of Development

Trevor Reeve

Director, Preconstruction, Bouygues UK

Colin Brown

Director - Development, Mission Street

Sophie Goddard

Director of Sustainability, Canary Wharf Group

Fatos Peja

Design Principal, HDR

Moderator

Rob Burborough

Partner, 3PM

Charting The Future: Listening To Tenants And Modifying Real Estate

Discover How To Best Future Proof Your Lab Space In Response To Tenant's Demands

Matt Smith

Partner, DTRE

Elie Gamburg

Design Principal, Kohn Pedersen Fox Associates

Mairi Dillon

Ecosystem Manager UK & Ireland, Kadans Science Partner

Moderator

Mike Phillips

UK Editor, Bisnow

Keynote Fireside Chat

Exploring How To Build A Life Science's Cluster

Mark Caulfield

Professor Sir Mark Caulfield is Professor of Clinical Pharmacology at Queen Mary University of London and the Vice Principal for Health for Queen Mary’s Faculty of Medicine and Dentistry. Professor Caulfield graduated in Medicine in 1984 from the London Hospital Medical College and trained in Clinical Pharmacology at St Bartholomew’s Hospital where he developed a research programme in molecular genetics of hypertension and translational clinical research. At Queen Mary University of London Professor Caulfield has made substantial contributions to the discovery of genes related to blood pressure, cardiovascular health, cancer and rare diseases. His research has changed national and international guidance for high blood pressure. He was Director of Queen Mary’s William Harvey Research Institute between 2002-2020 and was elected to the Academy of Medical Sciences in 2008. He has won the Lily Prize of the British Pharmacology Society, the Bjorn Folkow Award of the European Society of Hypertension 2016 and the Franz Volhard Award of the International Society of Hypertension in 2018. Professor Caulfield was appointed Chief Scientist for Genomics England in 2013, charged with delivery of the 100,000 Genomes Project on whole genome sequencing in rare disease, cancer and infection. At Genomics England, he was instrumental in delivering the 100,000 Genomes Project which has delivered life-changing results for many patients. He has also worked with NHS England to co-create the National Genomic Test Directory, which offers equitable access for 56 million people to appropriate genomic tests. Professor Caulfield was awarded a knighthood in 2019 for his leadership of the 100,000 Genomes Project. He is a member of the Barts Health NHS Trust Board, the Barking, Havering and Redbridge University Hospitals NHS Trust, the MedCity Board and is the President Elect of the British Pharmacological Society.

Queen Mary University of London

Vice Principal for Health

Mark Caulfield

Vice Principal for Health, Queen Mary University of London

Catherine Byers

Chief Finance + Performance Officer, Genomics England

Guy Woodhouse

Guy joined Piercy&Company in 2012. He was promoted to associate in 2018, and studio director in 2022. He has expertise in leading large-scale residential, commercial, and mixed use developments, and in working collaboratively alongside other design professionals as part of strategic master-plans and place-making projects. He has played a key role in the successful design and delivery of a range of projects for the studio. Guy is leading Regent Quarter at King’s Cross for Endurance Land and Nan Fung. The heritage and public-realm led masterplan for the 3.5 acre site is part of the client’s ten-year vision to revitalise the estate and create a vibrant new urban quarter for London. Phase 2 is currently underway to extend and refurbish three existing buildings - Jahn Court, Times House and Laundry Buildings - to create a trio of new life science buildings for London’s Knowledge Quarter. Guy was project lead for two residential buildings at Harrow View East for Barratt London, and a series of market and affordable residential buildings for Phases 3 and 5 of East Wick & Sweetwater at the Queen Elizabeth Olympic Park for Balfour Beatty and Places for People. Other projects include Skipton House - a sustainable refurbishment and extension of an existing office building for London&Regional, North Kensington Library - a new civic building for the Royal Borough of Kensington and Chelsea, and Two Tabernacle Street - a RIBA award-winning office building in Islington for Durley Investment Corporation. Guy is a graduate of the Cambridge Institute of Sustainability in Leadership for the Built Environment. He is helping to lead the studio’s efforts to engage with issues around sustainability and resilience, including the organisation of internal training and expert design clinics, continued review of internal design strategies and progressing the studio’s applications for UKGBC Net Zero and Science-based Targets accreditation. Guy leads Piercy&Company’s cultural programme of events and invited lectures. This recently culminated in staging ‘Supermodels’, an exhibition of innovative architectural models that sought to engage architectural ideas with a wider audience. It received extensive coverage in both national and international design press. Outside of his professional work he has exhibited work at arts festivals both in the UK and abroad, and has been an invited design critic at the Bartlett School of Architecture, Harvard Graduate School of Design, the University for the Creative Arts, and the SEA, Cape Town.

Piercy&Co

Studio Director

Moderator

Guy Woodhouse

Studio Director, Piercy&Co

Why This Matters

What You'll Learn:

What makes a life science hub attractive to an investor, and what local efforts can life science hubs prioritise to secure future investment.
The appropriate amount of due diligence required ahead of selecting a site to develop on.
How to prioritise the speed of delivery without compromising quality.
How facilities can be designed to attract exciting tenants and drive innovation.
Drug discovery, vaccine development and other innovation in life sciences in 2023, and how this has impacted life sciences real estate innovation in design in space.

How You'll Do More Business: Despite the current economic environment, demand for Life Sciences real estate has continued to encourage significant investment. According to DTRE take-up for science-related real estate across the golden triangle of London, Oxford and Cambridge totalled 1.26M SF in 2022, the highest figure in the past five years. Life science and biotech companies based in the golden triangle have also managed to secure £2B of funding over the same time period — ahead of pre-pandemic levels. The combination of these factors, alongside a continued supply demand imbalance have continued to attract vast quantities of investment from domestic and international companies in 2023... but will this continue into 2024? Hear from our expert speakers on the opportunities and challenges of attracting investment as a life sciences hub moving forward, the appropriate considerations required before embarking on development, and how to listen to your tenants to future proof your lab space.

Questions about your ticket or booking? Reach out to customerservice@bisnow.com. For other questions, comments or press enquiries, email our UK Events Manager, Louis, at louis.chandor@bisnow.com.

To request disability-related accommodations, please contact lucrezia.manzo@bisnow.com no later than seven business days prior to the event.

Share your comments, post your photos and ask questions using #BisnowEurope on Twitter and Instagram, and follow us at @BisnowEurope on Twitter for more local news.

Venue

Level 10, 20 Water Street
London, E14 9QG

Parking Information:

https://canarywharf.com/getting-here/

Get Directions

Agenda

Time	Activity
2:00 PM 2:40 PM	Welcome, Registration And Networking
2:40 PM 2:45 PM	Welcome From Bisnow And DTRE
2:45 PM 2:50 PM	Introduction To The Asset From Canary Wharf And Kadans
2:50 PM 3:35 PM	Life Science Platform Investment Insights: Strategies, Risks, And Returns 1. What makes a life science hub attractive to an investor? 2. What are the key roadblocks in the life science market that ward off investors? 3. How are investors seeking to diversify their investment portfolio to ensure resilience in the future market?
3:35 PM 4:20 PM	Smart Sites: Examine The Key Costs & Considerations In Construction And Development 1. What is the appropriate due diligence required ahead of selecting a site to develop on? 2. How are rising costs of materials, securing finance for construction, and construction delays impacting development strategies, and what are you doing to overcome these challenges moving forward? 3. What role does sustainability play in the design and development of life sciences spaces, and how are you seeking to incorporate green practices into these current and future projects?
4:20 PM 4:40 PM	Stretch Your Legs Break
4:40 PM 5:00 PM	Keynote Fireside Chat How can you build the best life science's cluster
5:00 PM 5:45 PM	Charting The Future: Listening To Tenants And Modifying Real Estate 1. How has drug discovery, vaccine development and other innovation in Life Sciences in 2023 impacted life sciences real estate innovation? 2. How can the way in which facilities are designed attract exciting tenants and drive innovation? 3. What are you doing to future-proof your lab spaces?
5:45 PM 6:30 PM	Site Tours Powered By Canary Wharf And Kadans
5:45 PM 6:30 PM	Networking